Medicare’s prescription drug coverage provision—known as Medicare Part D—doesn’t expressly prohibit state governments and insurance departments from imposing price structures or interfering with contract negotiations between Part D plan sponsors and pharmacies, the U.S. District Court for the Western District of Louisiana said.
The federal law and its implementing regulations thus don’t provide a basis for conflict preemption requiring dismissal of this ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.